Yajing Liu Selected Research

Semicarbazones

1/2021	Design, synthesis, and biological activity of novel semicarbazones as potent Ryanodine receptor1 inhibitors of Alzheimer's disease.
1/2020	Design, Synthesis and Biological Evaluation of Novel 4-phenoxypyridine Derivatives Containing Semicarbazones Moiety as Potential c-Met Kinase Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yajing Liu Research Topics

Disease

66	Neoplasms (Cancer) 03/2024 - 05/2011
14	Breast Neoplasms (Breast Cancer) 10/2023 - 11/2009
10	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 11/2010
6	Stomach Neoplasms (Stomach Cancer) 05/2024 - 01/2017
6	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2014
6	Infections 12/2023 - 10/2012
6	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 09/2023 - 01/2019
5	Carcinogenesis 01/2023 - 04/2012
5	Hypoxia (Hypoxemia) 11/2021 - 05/2011
4	Insulin Resistance 08/2023 - 01/2018
3	Endometriosis 01/2024 - 09/2020
3	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 11/2020
3	Triple Negative Breast Neoplasms 01/2020 - 08/2016
2	Lung Neoplasms (Lung Cancer) 02/2024 - 01/2023
2	Brain Neoplasms (Brain Tumor) 11/2023 - 10/2023
2	Glioma (Gliomas) 10/2023 - 04/2019
2	Adenocarcinoma 10/2023 - 11/2017
2	Bacterial Infections (Bacterial Infection) 10/2023 - 01/2022
2	Ankylosing Spondylitis 02/2023 - 06/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 10/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 12/2022 - 01/2018
2	Inflammation (Inflammations) 12/2022 - 01/2022
2	Memory Disorders (Memory Loss) 11/2022 - 01/2020
2	Periodontitis 01/2022 - 07/2021
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 08/2021
2	Cicatrix (Scar) 01/2021 - 02/2016
2	Carcinoma (Carcinomatosis) 01/2021 - 02/2018
2	Melanoma (Melanoma, Malignant) 10/2020 - 11/2018
2	Body Weight (Weight, Body) 04/2020 - 01/2019
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 01/2018
2	Parkinson Disease (Parkinson's Disease) 06/2014 - 10/2012
1	Pathologic Processes 05/2024
1	Multiple Myeloma 04/2024
1	Obesity 04/2024

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 05/2024 - 11/2009
9	Phosphotransferases (Kinase)IBA 01/2023 - 11/2014
6	LipidsIBA 04/2024 - 01/2018
5	Amyloid (Amyloid Fibrils)IBA 11/2021 - 11/2010
4	Estrogen ReceptorsIBA 10/2023 - 02/2020
4	Mitochondrial DNA (mtDNA)IBA 09/2023 - 09/2020
4	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2023 - 01/2020
4	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 01/2017
4	Therapeutic UsesIBA 10/2022 - 10/2016
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 02/2016
3	MicroRNAs (MicroRNA)IBA 05/2024 - 11/2018
3	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2023
3	Oncogene Proteins (Oncogene Protein)IBA 03/2024 - 01/2023
3	Transcription Factors (Transcription Factor)IBA 02/2024 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2015
3	Insulin (Novolin)FDA Link 10/2023 - 11/2022
3	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 07/2021
3	Messenger RNA (mRNA)IBA 02/2023 - 10/2020
3	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2021
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 01/2018
3	EnzymesIBA 01/2022 - 11/2019
3	CytokinesIBA 01/2022 - 01/2017
3	MelatoninIBA 01/2022 - 01/2021
3	Long Noncoding RNAIBA 02/2021 - 01/2018
3	AntigensIBA 01/2021 - 10/2016
2	Monoclonal AntibodiesIBA 04/2024 - 01/2022
2	CholesterolIBA 02/2024 - 06/2020
2	Trastuzumab (Herceptin)FDA Link 02/2024 - 08/2016
2	Trace Elements (Biometals)IBA 01/2024 - 05/2023
2	Glutamine (L-Glutamine)FDA Link 10/2023 - 01/2019
2	Amino Acids FDA Link 10/2023 - 12/2019
2	Phenobarbital (Luminal)FDA Link 10/2023 - 01/2014
2	ErbB Receptors (EGF Receptor)IBA 10/2023 - 12/2021
2	Hormones (Hormone)IBA 01/2023 - 12/2021
2	Indicators and Reagents (Reagents)IBA 01/2023 - 10/2016
2	Amyloid beta-PeptidesIBA 01/2023 - 10/2021
2	2-aminopyrimidineIBA 01/2023 - 12/2021
2	Small Interfering RNA (siRNA)IBA 02/2022 - 01/2017
2	Aromatase (CYP19)IBA 01/2022 - 02/2020
2	PlatinumIBA 01/2022 - 11/2021
2	Gemcitabine FDA Link 11/2021 - 11/2020
2	SemicarbazonesIBA 01/2021 - 01/2020
2	Histone Deacetylase InhibitorsIBA 01/2021 - 01/2020
2	CaspasesIBA 11/2020 - 08/2015
2	Silicon Dioxide (Silica)FDA LinkGeneric 10/2020 - 11/2017
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2020 - 02/2016
2	Glutathione (Reduced Glutathione)IBA 10/2020 - 09/2017
2	Protein Disulfide-IsomerasesIBA 01/2019 - 01/2019
2	fluoromisonidazoleIBA 01/2019 - 05/2011
2	NitroimidazolesIBA 01/2019 - 05/2011
2	ProdrugsIBA 02/2018 - 09/2017
2	VaccinesIBA 11/2016 - 10/2016
2	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 06/2014 - 10/2012
1	daratumumabIBA 04/2024
1	lycium barbarum polysaccharideIBA 04/2024
1	Sirtuin 1IBA 04/2024

Therapy/Procedure

21	Therapeutics 01/2023 - 11/2009
9	Drug Therapy (Chemotherapy) 02/2024 - 01/2014
5	Immunotherapy 01/2023 - 03/2019
2	Oral Administration 01/2023 - 01/2023
2	Precision Medicine 01/2023 - 09/2017
2	Neoadjuvant Therapy 11/2022 - 11/2022
2	Microbubbles 02/2022 - 01/2021
2	Photochemotherapy (Photodynamic Therapy) 10/2020 - 02/2016
2	Radiotherapy 03/2019 - 01/2019